In medulloblastoma, SHH/Gli has been shown to drive expression of stem cell modulator Bmi1, a key transcriptional polycomb repressor, found to be overexpressed in medulloblastoma and in CD133+ tumor initiating progenitors [164,165,166,167]. Here, PROM1 is linked to neoplasm.